A Double Fail-Safe Approach to Prevent Tumorigenesis and Select Pancreatic β Cells from Human Embryonic Stem Cells
Open Access
- 1 March 2019
- journal article
- research article
- Published by Elsevier in Stem Cell Reports
- Vol. 12 (3) , 611-623
Abstract
No abstract availableKeywords
Funding Information
- Juvenile Diabetes Research Foundation (5-2006-392)
- Diabetes Research Institute Foundation
This publication has 39 references indexed in Scilit:
- Human telomerase reverse-transcriptase promoter-controlled and herpes simplex virus thymidine kinase-armed adenoviruses for renal cell carcinoma treatmentOncoTargets and Therapy, 2013
- A Scalable System for Production of Functional Pancreatic Progenitors from Human Embryonic Stem CellsPLOS ONE, 2012
- FDA scrutinizes human stem cell therapiesNature Biotechnology, 2008
- Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivoNature Biotechnology, 2008
- Mutagenesis and Oncogenesis by Chromosomal Insertion of Gene Transfer VectorsHuman Gene Therapy, 2006
- Ready or Not? Human ES Cells Head Toward the ClinicScience, 2005
- Suicide gene transduction sensitizes murine embryonic and human mesenchymal stem cells to ablation on demand – a fail-safe protection against cellular misbehaviorGene Therapy, 2002
- T cell transduction and suicide with an enhanced mutant thymidine kinaseGene Therapy, 2002
- Gap junctions: the “kiss of death” and the “kiss of life”Brain Research Reviews, 2000
- A Phase I/II Dose-Escalation Study of Herpes Simplex Virus Type 1 Thymidine Kinase “Suicide” Gene Therapy for Metastatic MelanomaHuman Gene Therapy, 1998